1
Clinical Trials associated with Recombinant hepatitis B vaccine (Hansenula polymorpha yeast, CpG-ODN adjuvanted)(Yunnan Walvax Biotech/Changchun Huapu Biotechnology)随机化盲法对照研究评估20微克重组(汉逊酵母)乙型肝炎疫苗接种于16岁及以上人群预防乙肝的安全性和免疫原性。
[Translation] A randomized, blinded, controlled study evaluating the safety and immunogenicity of 20 μg of recombinant (Hansenula) hepatitis B vaccine for the prevention of hepatitis B in people aged 16 years and older.
评价重组(汉逊酵母)乙型肝炎疫苗(20μg/0.5ml/支)应用于16岁及以上健康人群预防乙肝的安全性和免疫效果。
[Translation] To evaluate the safety and immune efficacy of recombinant (Hansen yeast) hepatitis B vaccine (20 μg/0.5 ml/vial) for the prevention of hepatitis B in healthy people aged 16 years and above.
100 Clinical Results associated with Recombinant hepatitis B vaccine (Hansenula polymorpha yeast, CpG-ODN adjuvanted)(Yunnan Walvax Biotech/Changchun Huapu Biotechnology)
100 Translational Medicine associated with Recombinant hepatitis B vaccine (Hansenula polymorpha yeast, CpG-ODN adjuvanted)(Yunnan Walvax Biotech/Changchun Huapu Biotechnology)
100 Patents (Medical) associated with Recombinant hepatitis B vaccine (Hansenula polymorpha yeast, CpG-ODN adjuvanted)(Yunnan Walvax Biotech/Changchun Huapu Biotechnology)
100 Deals associated with Recombinant hepatitis B vaccine (Hansenula polymorpha yeast, CpG-ODN adjuvanted)(Yunnan Walvax Biotech/Changchun Huapu Biotechnology)